We only have this paper's title and publication details.
Read it at the sourceCo-targeting Bcl-xL and Mcl-1 improved effects in CRPC cell models, suggesting a new treatment approach.
Table S1 depicts the IC50 values of BH3 mimetics as single agents in 2D models.
No takes yet. Share an insight, caveat, or question.
Brim et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: